AI-driven liquid biopsy technology breaks through, accurately targeting early-stage cancer October 29, 2025 Read more »
Gakken Group has established a new company in collaboration with Kyoto University to strengthen measures against age-related diseases in response to the aging population. October 13, 2025 Read more »
The innovative stem cell gene therapy OTL-200 has been officially approved in Japan, bringing hope to children with the rare disease MLD. October 11, 2025 Read more »
